XML 20 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Condensed Statements of Equity - USD ($)
$ in Millions
Total
Preferred Stock
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Non-controlling Interests
Beginning balance at Dec. 31, 2022 $ 30,085 $ 9,762 $ 220 $ (13,772) $ 17,181 $ 16,499 $ 195  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 2,123         2,123    
Other comprehensive income (loss), net of tax 52           52  
Dividends on common stock (325)         (325)    
Dividends on preferred stock (390)         (390)    
Preferred stock redemption - face value (1,169) (1,169)            
Preferred stock redemption - premium (117)         (117)    
Preferred stock redemption value in excess of carrying value 0 28       (28)    
Shareholder warrants exercised 3       3      
Options exercised 13       13      
Issuance of common stock and other, net of cancellations 22   1   21      
Purchases of treasury stock (1,186)     (1,186)        
Ending balance at Jun. 30, 2023 29,111 8,621 221 (14,958) 17,218 17,762 247  
Beginning balance at Mar. 31, 2023 29,559 9,130 221 (14,524) 17,159 17,318 255  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 860         860    
Other comprehensive income (loss), net of tax (8)           (8)  
Dividends on common stock (161)         (161)    
Dividends on preferred stock (190)         (190)    
Preferred stock redemption - face value (522) (522)            
Preferred stock redemption - premium (52)         (52)    
Preferred stock redemption value in excess of carrying value 0 13       (13)    
Shareholder warrants exercised 1       1      
Options exercised 6       6      
Issuance of common stock and other, net of cancellations 52       52      
Purchases of treasury stock (434)     (434)        
Ending balance at Jun. 30, 2023 29,111 8,621 221 (14,958) 17,218 17,762 247  
Beginning balance at Dec. 31, 2023 30,250              
Beginning balance, including NCI at Dec. 31, 2023 30,349 8,287 222 (15,582) 17,422 19,626 275 $ 99
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 2,058         2,050   8
Other comprehensive income (loss), net of tax (11)           (11)  
Dividends on common stock (398)         (398)    
Dividends on preferred stock (340)         (340)    
Shareholder warrants exercised 487   4   483      
Issuance of common stock and other, net of cancellations 24   1   23      
Purchases of treasury stock (9)     (9)        
Noncontrolling interest contributions 99             99
Ending balance, including NCI at Jun. 30, 2024 32,259 8,287 227 (15,591) 17,928 20,938 264 206
Ending balance at Jun. 30, 2024 32,053              
Beginning balance, including NCI at Mar. 31, 2024 30,967 8,287 223 (15,582) 17,456 20,147 280 156
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 1,170         1,162   8
Other comprehensive income (loss), net of tax (16)           (16)  
Dividends on common stock (201)         (201)    
Dividends on preferred stock (170)         (170)    
Shareholder warrants exercised 415   4   411      
Issuance of common stock and other, net of cancellations 61       61      
Purchases of treasury stock       (9)        
Noncontrolling interest contributions 42             42
Ending balance, including NCI at Jun. 30, 2024 32,259 $ 8,287 $ 227 $ (15,591) $ 17,928 $ 20,938 $ 264 $ 206
Ending balance at Jun. 30, 2024 $ 32,053